Skip to main content

Table 4 One year follow-up and outcome data for the studied group of ten living-related renal transplant recipients

From: The feasibility and applications of non-invasive cardiac output monitoring, thromboelastography and transit-time flow measurement in living-related renal transplantation surgery: results of a prospective pilot observational study

Patient DGF Thromboembolic graft complication VTE Haemorrhagic graft complication Rejection Treatment for rejection Creatinine 6 months Creatinine 1 year Dialysis (at 1 yr)
   Yes/No Type   Yes/No Type Yes/No Type     
P1 a No   Yes Large perigraft haematoma Yes Early acute rejection. bATG for early rejection; successful 115 286 Yes
Chronic antibody mediated rejection from 9 months eCampath, no benefit
P2 No   No   No    120 111 No
P3 Yes Intra-operative transplant artery thrombosis - surgically corrected No   No    84 87 No
P4 No   No   No    67 79 No
P5      Yes Antibody mediated acute rejection cause of cDGF Early short term dialysis. ATG, Methylprednisolone, dMMF; successful 104 130 No
P6 No   No   Yes Acute early rejection ATG; successful 134 101 No
P7 No   No   Yes Early antibody mediated rejection Pulsed oral prednisolone regimen; successful 144 123 No
P8 No   No   No    129 129 No
P9 No   No   Yes Early antibody mediated rejection Pulsed oral prednisolone regimen; successful 103 114 No
P10    No   No     132 No
  1. aPatient (P) 1 demonstrated graft failure within 1-year as defined by a return to dialysis-dependent status. bATG, anti-thymocyte globulin; cDGF, delayed graft function; dMMF, mycophenolate mofetil; eCampath, Alemtuzumab.